Johann de Bono, MD, PhD

Johann de Bono, MD, PhD
About Johann de Bono, MD, PhD

Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.


Institute of Cancer Research


Medical Oncology